All News

Clinical Trials

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers
23 March 2023
Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers
Kite’s Yescarta CAR-T cell therapy
GOSH Enters into Agreement with Leucid Bio at a New Therapy Manufacturing Center
16 March 2023
GOSH Enters into Agreement with Leucid Bio at a New Therapy Manufacturing Center
Leucid Bio, announced an agreement
Pfizer Invests $43 Billion to Acquire Seagen
14 March 2023
Pfizer Invests $43 Billion to Acquire Seagen
Pfizer is to acquire global
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
8 March 2023
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
Adaptimmune Theraputics and TCR2 Theraputics
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

Early Adoption and Partnerships – The Secret to Commercialization Success?
2 March 2023
Early Adoption and Partnerships – The Secret to Commercialization Success?
This Briefing from Advanced Therapies
Mesoblast Phase III Cell Therapy Shows Promise Against Heart Failure  
28 February 2023
Mesoblast Phase III Cell Therapy Shows Promise Against Heart Failure  
Mesoblast has announced that the
First Gene Therapy for Hemophilia B Approved by the European Commission
24 February 2023
First Gene Therapy for Hemophilia B Approved by the European Commission
UniQure and its global biotechnology
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
15 February 2023
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
Heartseed Inc (Tokyo, Japan) and
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?